Yuanbo Xue

682 total citations
14 papers, 488 citations indexed

About

Yuanbo Xue is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuanbo Xue has authored 14 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuanbo Xue's work include Epigenetics and DNA Methylation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Yuanbo Xue is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Yuanbo Xue collaborates with scholars based in China and United States. Yuanbo Xue's co-authors include Ruilei Li, Qiaofen Fu, Baozhen Zeng, Xin Song, Xin Song, Chunlei Ge, Ying Wang, Zhen Li, Heng Li and Nan Chen and has published in prestigious journals such as American Journal Of Pathology, Journal of Hematology & Oncology and Oncotarget.

In The Last Decade

Yuanbo Xue

14 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanbo Xue China 12 248 247 180 122 59 14 488
Liangliang Yang China 8 133 0.5× 245 1.0× 100 0.6× 208 1.7× 89 1.5× 10 436
Pei‐Chi Hou Taiwan 10 90 0.4× 226 0.9× 73 0.4× 121 1.0× 63 1.1× 16 409
Miki Yamaguchi Japan 13 184 0.7× 76 0.3× 108 0.6× 88 0.7× 35 0.6× 33 436
Adeline Bouard France 8 251 1.0× 171 0.7× 139 0.8× 79 0.6× 62 1.1× 17 396
D-A Silasi United States 6 168 0.7× 147 0.6× 140 0.8× 87 0.7× 50 0.8× 12 428
Naoshi Kawamura Japan 10 233 0.9× 156 0.6× 204 1.1× 57 0.5× 46 0.8× 12 456
Kunpeng Lv China 14 271 1.1× 142 0.6× 274 1.5× 88 0.7× 109 1.8× 19 484
Hye Jeong Oh South Korea 7 198 0.8× 156 0.6× 99 0.6× 74 0.6× 58 1.0× 14 381
Angela M. Araujo Spain 7 145 0.6× 249 1.0× 110 0.6× 194 1.6× 55 0.9× 9 468

Countries citing papers authored by Yuanbo Xue

Since Specialization
Citations

This map shows the geographic impact of Yuanbo Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanbo Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanbo Xue more than expected).

Fields of papers citing papers by Yuanbo Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanbo Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanbo Xue. The network helps show where Yuanbo Xue may publish in the future.

Co-authorship network of co-authors of Yuanbo Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanbo Xue. A scholar is included among the top collaborators of Yuanbo Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanbo Xue. Yuanbo Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Cao, Huijun, Zhiqiang Wang, Ying Wang, et al.. (2022). PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway. International Journal of Oncology. 61(6). 3 indexed citations
3.
Xue, Yuanbo, et al.. (2020). A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma. Technology in Cancer Research & Treatment. 19. 1079203508–1079203508. 11 indexed citations
4.
Ge, Chunlei, Baozhen Zeng, Ruilei Li, et al.. (2019). Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts. Bioengineered. 10(1). 425–436. 11 indexed citations
5.
Zeng, Baozhen, Chunlei Ge, Ruilei Li, et al.. (2019). Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. Biomedicine & Pharmacotherapy. 121. 109562–109562. 33 indexed citations
6.
Fu, Qiaofen, Nan Chen, Ruilei Li, et al.. (2019). Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis. OncoImmunology. 8(7). e1593806–e1593806. 183 indexed citations
7.
Fu, Qiaofen, Yuhui Huang, Chunlei Ge, et al.. (2019). SHIP1 inhibits cell growth, migration, and invasion in non‑small cell lung cancer through the PI3K/AKT pathway. Oncology Reports. 41(4). 2337–2350. 14 indexed citations
8.
Jiang, Honghong, Qiaofen Fu, Xin Song, et al.. (2019). HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma. Oncology Letters. 24 indexed citations
9.
Li, Ruilei, Haifeng Song, Tao Geng, et al.. (2017). Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC. BMC Cancer. 17(1). 884–884. 36 indexed citations
10.
Li, Zhen, Zhimin Liu, Suwei Dong, et al.. (2015). miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer. American Journal Of Pathology. 185(9). 2412–2420. 31 indexed citations
11.
Dong, Suwei, Liang Zeng, Zhimin Liu, et al.. (2015). NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. Journal of Hematology & Oncology. 8(1). 120–120. 32 indexed citations
12.
Ge, Chunlei, Shikai Wu, Weiwei Wang, et al.. (2015). miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway. Oncotarget. 6(13). 10964–10977. 57 indexed citations
13.
Li, Zhen, Ying Wang, Chunlei Ge, et al.. (2014). Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro. Cytokine. 69(1). 6–13. 32 indexed citations
14.
Chen, Xiaodan, Zhimin Liu, Yunchao Huang, et al.. (2013). Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma. Autoimmunity. 47(1). 46–56. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026